Results 21 to 30 of about 14,409 (206)

Hypereosinophilia is a predictive biomarker of immune checkpoint inhibitor-induced hypopituitarism in patients with renal cell carcinoma

open access: yesBMC Endocrine Disorders, 2022
Background This study aimed to evaluate whether hypereosinophilia is a clinical biomarker of immune checkpoint inhibitor-induced hypopituitarism in patients with renal cell carcinoma treated with nivolumab plus ipilimumab.
Hodaka Yamada   +11 more
doaj   +1 more source

Lipid profile and response to statin therapy in patients with hypopituitarism

open access: yesArchives of Endocrinology and Metabolism, 2020
Objective: Dyslipidemia is prevalent among patients with hypopituitarism, especially in those with growth hormone (GH) deficiency. This study aimed to evaluate the response to statin therapy among adult patients with dyslipidemia and hypopituitarism ...
Graziela Rissetti   +5 more
doaj   +1 more source

Clinical Presentation of Congenital Hypopituitarism: Lessons From a Large Academic Centre. [PDF]

open access: yesClin Endocrinol (Oxf)
ABSTRACT Objective Pituitary hormone deficiencies are associated with considerable morbidity, yet the variability of presentation and evolution of congenital hypopituitarism remains unexplored. This study investigated differences in presentation of congenital isolated pituitary hormone deficiency (cIPHD) versus congenital multiple pituitary hormone ...
Ladd JM   +4 more
europepmc   +2 more sources

Cholestasis and hypercalcemia secondary to panhypopituitarism in a newborn

open access: yesThe Turkish Journal of Pediatrics, 2017
Cholestatic hepatitis and hypercalcemia are rare features of hypopituitarism in newborns. So diagnosis of hypopituitarism is frequently delayed.
Fatma Dursun   +2 more
doaj   +1 more source

Advances in understanding hypopituitarism [version 1; referees: 2 approved]

open access: yesF1000Research, 2017
The understanding of hypopituitarism has increased over the last three years. This review provides an overview of the most important recent findings. Most of the recent research in hypopituitarism has focused on genetics.
Mareike R. Stieg   +3 more
doaj   +1 more source

Recognition and Practice of Hypopituitarism After Traumatic Brain Injury and Subarachnoid Hemorrhage in Japan: A Survey

open access: yesNeurology and Therapy, 2023
Introduction Individuals with traumatic brain injury (TBI) or subarachnoid hemorrhage (SAH) are at a high risk of hypopituitarism, and should benefit from early diagnosis and management.
Shigeyuki Tahara   +2 more
doaj   +1 more source

Management of hypopituitarism: a perspective from the Brazilian Society of Endocrinology and Metabolism

open access: yesArchives of Endocrinology and Metabolism, 2021
Hypopituitarism is a disorder characterized by insufficient secretion of one or more pituitary hormones. New etiologies of hypopituitarism have been recently described, including head trauma, cerebral hemorrhage, and drug-induced hypophysitis.
Heraldo Mendes Garmes   +16 more
doaj   +1 more source

Evidence That the Etiology of Congenital Hypopituitarism Has a Major Genetic Component but Is Infrequently Monogenic

open access: yesFrontiers in Genetics, 2021
PurposeCongenital hypopituitarism usually occurs sporadically. In most patients, the etiology remains unknown.MethodsWe studied 13 children with sporadic congenital hypopituitarism. Children with non-endocrine, non-familial idiopathic short stature (NFSS)
Youn Hee Jee   +14 more
doaj   +1 more source

Genetic diagnosis of congenital hypopituitarism by a target gene panel: novel pathogenic variants in GLI2, OTX2 and GHRHR

open access: yesEndocrine Connections, 2019
Aim: Congenital hypopituitarism has an incidence of 1:3500–10,000 births and is defined by the impaired production of pituitary hormones. Early diagnosis has an impact on management and genetic counselling.
Marilena Nakaguma   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy